U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C19H23N5O2
Molecular Weight 353.4182
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of JNJ-42396302

SMILES

COCCC1=CC=C(C=N1)C2=C(C)N=C3N2N=CC=C3N4CCOCC4

InChI

InChIKey=BPLVDYJDAVYLRQ-UHFFFAOYSA-N
InChI=1S/C19H23N5O2/c1-14-18(15-3-4-16(20-13-15)6-10-25-2)24-19(22-14)17(5-7-21-24)23-8-11-26-12-9-23/h3-5,7,13H,6,8-12H2,1-2H3

HIDE SMILES / InChI
Molecular Formula C19H23N5O2
Molecular Weight 353.4182
Charge 0
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Description

JNJ-42396302 was under investigation in clinical trial NCT01732237 (A Study to Investigate the Pharmacokinetics of JNJ-42396302, JNJ-53773187, and JNJ-42692507 in Healthy Male Participants).

Originator

Approval Year

Unknown
139594
Patents

Patents

20110269752
1

Sample Use Guides

In Vivo Use Guide
Patients will receive JNJ-42396302 100 micrograms as a single oral dose after an overnight fast of at least 10 hours.
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Sat Dec 16 09:46:41 GMT 2023
Edited
by admin
on Sat Dec 16 09:46:41 GMT 2023
Record UNII
P5M4972608
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
JNJ-42396302
Common Name English
IMIDAZO(1,2-B)PYRIDAZINE, 3-(6-(2-METHOXYETHYL)-3-PYRIDINYL)-2-METHYL-8-(4-MORPHOLINYL)-
Systematic Name English
Code System Code Type Description
PUBCHEM
51352628
Created by admin on Sat Dec 16 09:46:41 GMT 2023 , Edited by admin on Sat Dec 16 09:46:41 GMT 2023
PRIMARY
FDA UNII
P5M4972608
Created by admin on Sat Dec 16 09:46:41 GMT 2023 , Edited by admin on Sat Dec 16 09:46:41 GMT 2023
PRIMARY
CAS
1298030-18-8
Created by admin on Sat Dec 16 09:46:41 GMT 2023 , Edited by admin on Sat Dec 16 09:46:41 GMT 2023
PRIMARY
DRUG BANK
DB12657
Created by admin on Sat Dec 16 09:46:41 GMT 2023 , Edited by admin on Sat Dec 16 09:46:41 GMT 2023
PRIMARY
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966